Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
A multicentre, interventional, double-blind, placebo-controlled, parallel-arm, phase 3,
randomised controlled trial to evaluate the use of co-trimoxazole as primary prophylaxis for
spontaneous bacterial peritonitis to improve overall survival
Phase:
Phase 3
Details
Lead Sponsor:
University College, London
Collaborator:
National Institute for Health Research, United Kingdom